Dr. Robert William Irwin, MD

Dr. Irwin practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Irwin's NPI, 1689648990, was assigned on February 14, 2006. Dr. Irwin graduated from The University of New Mexico School of Medicine in 1992. Dr. Irwin holds Florida license ME 94516.

Dr. Irwin's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Irwin's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Irwin is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Irwin practices, 2 sites in all. Vendor and product names are available with a free account.

Physical medicine and rehabilitation is Dr. Irwin's primary specialty in the NPI Registry, under taxonomy code 208100000X. Dr. Irwin is board certified in electrodiagnostics by the American Board of Electrodiagnostic Medicine. Dmand AI has Dr. Irwin's licenses on file in 4 states: Florida, North Carolina, Louisiana and Illinois.

Dmand AI lists arthritis, back pain injection, fibromyalgia and chronic pain, joint pain, lower back pain, mobility impairment, muscle pain, fibromyalgia, and limb pain and neck pain and spine problems among the conditions Dr. Irwin treats.

CMS data shows 347 Medicare services from Dr. Irwin across 8 procedure codes in 2024, for 204 Medicare patients. Medicare paid $18,426 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 204 Medicare patients who saw Dr. Irwin in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have arthritis, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Irwin's median patient age at 72, with 69% women.

In 2024, Dr. Irwin wrote 557 Medicare Part D claims for 148 patients. 100% of them were for generic drugs. CMS names the drug for 517 of them, across 6 drugs with 11 or more claims each, at $5,487 in total drug cost. In 2023, CMS named 462 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Irwin for performance year 2024, reported as part of a group.

Dmand AI links 26 papers to Dr. Irwin, published from 2014 to 2024. 2014 was the busiest year, with 2. The most frequent topics are Spinal Cord Injuries, COVID-19 and Diagnosis, Differential. Dr. Irwin has published most often in Am J Phys Med Rehabil. Dr. Irwin's most frequent co-authors are Erin Thor Wolff, MD, Michael Appeadu, MD and Diana Cardenas, MD.

CMS Open Payments shows 1 general payment to Dr. Irwin from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Ipsen Biopharmaceuticals, Inc paid the most, $47.

Dmand AI lists 12 awards for Dr. Irwin, most recently CMS Stage 1 EHR in 2013.

Dr. Irwin graduated from The University of New Mexico School of Medicine in 1992. Dr. Irwin is a member of AAPMR, American Association of Neuromuscular and Electrodiagnostic Medicine and Association of Academic Physiatrists.

Dr. Irwin is in network with 6 carriers, including Elevance, United Healthcare and Blue Cross and Blue Shield of Kansas City. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.